Penn Medicine at Home
Bala-Cynwyd, Pennsylvania, 19004, United States
NCT Number: NCT05057364
The purpose of this capstone project is to pilot Heart Smart, a virtual group program to improve self-efficacy for self-management skills for homebound people with heart failure.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Bala-Cynwyd, Pennsylvania, 19004, United States
The purpose of this capstone project is to pilot Heart Smart, a virtual group program to improve self-efficacy for self-management skills for homebound people with heart failure. Heart Smart will provide synchronous virtual group education to homebound people with heart failure receiving services from Penn Medicine at Home. The primary clinical goal is to improve self-efficacy for heart failure self-management and improve their knowledge of heart failure self-management strategies. Secondary outcomes will explore the feasibility of the program by exploring technology, adherence and satisfaction with the program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Heart Smart Intervention is a 6 week virtual program consisting of one individual technology training session followed by 5 one hour group education sessions.
Time frame: At first and final sessions (weeks 1 and 6)
This self-report scale has 6 items which are each rated on a scale of 1 (not at all confident) to 10 (totally confident). The score for the scale is the mean of the scores for the six items. Possible scores are 1-10 with higher scores indicating higher self-efficacy. This scale is an appropriate outcome measure for a heart failure self-management group because it was designed to measure self-efficacy in people with chronic conditions such as heart failure and has undergone psychometric evaluation. This scale is free to use without permission. Administration takes less than 10 minutes.
Time frame: At first and final sessions (weeks 1 and 6)
This 23-item, Likert scale, self-report heart failure specific outcome measure. The instrument measures six domains: physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. This instrument is appropriate because it is designed for use for people with heart failure, will give an indication of participant heart failure severity for demographic purposes, and has a validated self-efficacy component. This scale requires a license which has been obtained for this pilot project. Administration takes less than 10 minutes. Scores range from 0 to 100 with higher scores indicating higher cardiac health status.
Time frame: At first and final sessions (weeks 1 and 6)
This 30 item multiple choice measure of heart failure self-management knowledge yields scores 0-30 which are commonly reported as a percentage (higher scores indicate more knowledge). Content validity was established through a panel of expert heart failure nurses.
Time frame: At each weekly session for 6 weeks
The number of participants at each meeting will be recorded.
Time frame: This will be recorded in the first session at week 1.
The number of minutes spent in the pre-training session will be recorded.
Time frame: At the final session on week 6
Participants will answer three likert scale questions.
Time frame: At each weekly session for 6 weeks.
Total number of minutes missed per participant per session.
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04179643
Arrhythmias, Cardiac, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT05384847
Cardiovascular Diseases, Heart Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT07743125
Cardiovascular Diseases, Heart Diseases
Menomonee Falls, Wisconsin, United States
View Trial DetailsNCT03446651
Cardiovascular Diseases, Heart Diseases
New Haven, Connecticut, United States
View Trial Details